CDK8-IN-3
Product Specifications
UNSPSC Description
CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7.
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CDK8-IN-3.html
Purity
99.21
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NCCOC)C1=CC=C2C(C(CC3=CC=C(C4=CN(C)N=C4)C=C3)=NN2)=C1
Molecular Weight
389.45
References & Citations
[1]Kai S, et al. Preparation of substituted indazoles as CDK8 inhibitors for treatment of proliferative diseases. WO 2016041618 A1 20160324
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111463/CDK8-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111463/CDK8-IN-3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1884500-15-5
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MAD2L1BP (CMT2, KIAA0110, MAD2L1-binding Protein, Caught by MAD2 Protein) (AP)
MAD2L1BP (CMT2, KIAA0110, MAD2L1-binding Protein, Caught by MAD2 Protein) (AP)